Assignee
ATOPIX THERAPEUTICS LTD
GB·6 granted patents·2 pending applications·9 citations·filing 2012–2015
Top patents by PatentIndex Score
8 records- 0179US8980927B2Compounds having CRTH2 antagonist activityATOPIX THERAPEUTICS LTD·Filed 2013·Granted Mar 17, 2015·3 cites·9 claims
- 0277US8980918B2Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acidATOPIX THERAPEUTICS LTD·Filed 2014·Granted Mar 17, 2015·3 cites·7 claims
- 0370US9102658B2Process for the preparation of (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-y1)-acetic acid estersATOPIX THERAPEUTICS LTD·Filed 2012·Granted Aug 11, 2015·3 cites·20 claims
- 0454US2015246030A1Compounds Having CRTH2 Antagonist ActivityATOPIX THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
- 0539US9828359B2Process for the preparation of 3-substituted (indol-1-yl)-acetic acid estersATOPIX THERAPEUTICS LTD·Filed 2014·Granted Nov 28, 2017·0 cites·22 claims
- 0638US10011584B2Polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene) sulfonyl]pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acidATOPIX THERAPEUTICS LTD·Filed 2015·Granted Jul 3, 2018·0 cites·19 claims
- 0735US2014328861A1Combination of CRTH2 Antagonist and a Proton Pump Inhibitor for the Treatment of Eosinophilic EsophagitisATOPIX THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
- 0833US9951042B2Polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene) sulfonyl] pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acidATOPIX THERAPEUTICS LTD·Filed 2015·Granted Apr 24, 2018·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →